Intrathecal Gadolinium-Enhanced MR Cisternography in the Evaluation of CSF Leakage

References

1. 1.↵
   1. Park J,
   2. Strelzow V,
   3. Friedman W

   . Current management of cerebrospinal fluid rhinorrhea. Laryngoscope 1983; 93: 1924–300
2. 2.↵
   1. Johnson DB,
   2. Brennan P,
   3. Toland J,
   4. et al

   . Magnetic resonance imaging in the evaluation of the cerebrospinal fluid fistula. Clin Radiol 1996; 51: 837–41

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Colquhoun IR

   . CT cisternography in the investigation of cerebrospinal rhinorrhea. Clin Radiol 1993; 47: 403–08

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Wakhloo AK,
   2. van Velthoven V,
   3. Shumacher M,
   4. et al

   . Evaluation of MR imaging, digital subtraction cisternography, and CT cisternography in diagnosing CSF fistula. Acta Neurochir (Wien) 1991; 111: 119–27

   CrossRefPubMed
5. 5.↵
   1. Manelfe C,
   2. Cellerier P,
   3. Sobel D,
   4. et al

   . Cerebrospinal fluid rhinorrhea: evaluation with metrizamide cisternography. AJR Am J Roentgenol 1982; 138: 471–76

   PubMed
6. 6.↵
   1. Nickaus P,
   2. Dutcher PO,
   3. Kido DK,
   4. et al

   . New imaging techniques in the diagnosis of cerebrospinal fluid fistula. Laryngoscope 1998; 98: 1065–68
7. 7.↵
   1. Ozgen T,
   2. Tekkok IH,
   3. Cila A,
   4. et al

   . CT cisternography in evaluation of cerebrospinal fluid rhinorrhea. Neuroradiology 1990; 32: 481–84

   CrossRefPubMed
8. 8.↵
   1. Lloyd MNH,
   2. Kimber PM,
   3. Burrows EH

   . Posttraumatic cerebrospinal fluid rhinorrhea: modern high-resolution computed tomography is all that is required for effective demonstration of the site of leakage. Clin Radiol 1994; 49: 100–03

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Ahmadi J,
   2. Weiss MH,
   3. Segall HD,
   4. et al

   . Evaluation of cerebrospinal fluid rhinorrhea by metrizamide computed tomography. Neurosurgery 1985; 16: 54–59

   PubMed
10. 10.↵
    1. Drayer BP,
    2. Wilkins RH,
    3. Boehnke M,
    4. et al

    . Cerebrospinal fluid rhinorrhea demonstrated by metrizamide CT cisternography. AJR Am J Roentgenol 1977; 129: 149–51

    PubMedWeb of Science
11. 11.↵
    1. Curnes JT,
    2. Vicent LM,
    3. Kowalsky RJ,
    4. et al

    . CSF rhinorrhea: detection and localization using overpressure cisternography with TC-99m-DTPA. Radiology 1985; 154: 795–99

    PubMedWeb of Science
12. 12.↵
    1. Stone JA,
    2. Castillo M,
    3. Neelon B,
    4. et al

    . Evaluation of CSF leaks: high-resolution CT compared with contrast-enhanced CT and radionuclide cisternography. AJNR Am J Neuroradiol 1999; 20: 706–12

    Abstract/FREE Full Text
13. 13.↵
    1. Murata Y,
    2. Yamada I,
    3. Suzuki S,
    4. et al

    . MRI in spontaneous cerebrospinal fluid rhinorrhea. Neuroradiology 1995; 37: 453–55

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Eljamel MS,
    2. Pidgeon CN,
    3. Toland J,
    4. et al

    . MRI cisternography and the localization of CSF fistula. Br J Neurosurg 1994; 8: 433–37

    CrossRefPubMed
15. 15.↵
    1. Eberhardt KE,
    2. Hollenbach HP,
    3. Deimling M,
    4. et al

    . MR cisternography: a new method for the diagnosis of CSF fistulae. Eur Radiol 1997; 7: 1485–91

    CrossRefPubMed
16. 16.↵
    1. El Gammal T,
    2. Brooks BS

    . MR cisternography: initial experience in 41 cases. AJNR Am J Neuroradiol 1994; 15: 1647–56

    Abstract/FREE Full Text
17. 17.↵
    1. Zlab MK,
    2. Moore GF,
    3. Daly DT,
    4. et al

    . Cerebrospinal fluid rhinorrhea: a review of the literature. Ear Nose Throat J 1992; 71: 314–17

    PubMed
18. 18.↵
    1. Gupta V,
    2. Goyal M,
    3. Mishra N,
    4. et al

    . MR evaluation of CSF fistulae. Acta Radiol 1997; 38: 603–09

    PubMedWeb of Science
19. 19.↵
    1. Sand T,
    2. Myhr G,
    3. Stovner LJ,
    4. et al

    . Side effects after lumbar iohexol myelography: relation to radiological diagnosis, sex and age. Neuroradiology 1990; 31: 523–28

    CrossRefPubMed
20. 20.↵
    1. Van de Kelft E,
    2. Bosmans J,
    3. Paziel P,
    4. et al

    . Intracerebral hemorrhage after lumbar myelography with iohexol: report of a case and review of the literature. Neurosurgery 1991; 28: 570–74

    PubMed
21. 21.↵
    1. Shetty PG,
    2. Shroff MM,
    3. Sahani DV,
    4. et al

    . Evaluation of high-resolution CT and MR cisternography in the diagnosis of cerebrospinal fluid fistula. AJNR Am J Neuroradiol 1998; 19: 633–39

    Abstract
22. 22.↵
    1. Wenzel R,
    2. Leppien A

    . Gadolinium-myelocisternography for cerebrospinal fluid rhinorrhoea. Neuroradiology 2000; 42: 874–80

    CrossRefPubMed
23. 23.↵
    1. Hegarty SE,
    2. Millar JS

    . MRI in the localization of CSF fistulae: is it of any value? Clin Radiol 1997; 52: 768–70

    CrossRefPubMed
24. 24.↵
    1. El Gammal T,
    2. Sobol W,
    3. Wadlington VR,
    4. et al

    . Cerebrospinal fluid fistula: detection with MR cisternography. AJNR Am J Neuroradiol 1998; 19: 627–31

    Abstract
25. 25.↵
    1. Chow JM,
    2. Goodman D,
    3. Mafee F

    . Evaluation of CSF rhinorrhea by computerized tomography with metrizamide. Otolaryngol Head Neck Surg 1989; 100: 99–105

    PubMed
26. 26.↵
    The National Academies Press. Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII-Phase 2. 2005Available at: http://books.nap.edu/catalog/11340.html. Accessed February 1, 2006
27. 27.↵
    1. Albayram S,
    2. Kilic F,
    3. Ozer H,
    4. et al

    . Gadolinium-enhanced MR cisternography to evaluate dural leaks in intracranial hypotension syndrome. AJNR Am J Neuroradiol 2008; 29: 116–21

    Abstract/FREE Full Text
28. 28.↵
    1. Niendorf HP,
    2. Haustein J,
    3. Cornelius I,
    4. et al

    . Safety of gadolinium-DTPA: extended clinical experience. Mag Reson Med 1991; 22: 222–28

    PubMedWeb of Science
29. 29.↵
    1. Niendorf HP,
    2. Haustein J,
    3. Louton T,
    4. et al

    . Safety and tolerance after intravenous administration of 0.3 mmol/kg Gd-DTPA: results of a randomized, controlled clinical trial. Invest Radiol 1991; 26: 221–23
30. 30.↵
    1. Goldstein HA,
    2. Kashanian FK,
    3. Blumetti RF,
    4. et al

    . Safety assessment of gadopentetate dimeglumine in US clinical trials. Radiology 1990; 174: 17–23

    PubMedWeb of Science
31. 31.↵
    1. Tardy B,
    2. Guy C,
    3. Barral G,
    4. et al

    . Anaphylactic shock induced by intravenous gadopentetate dimeglumine. Lancet 1992; 339: 494

    PubMedWeb of Science
32. 32.↵
    1. Perez-Rodriguez J,
    2. Lai S,
    3. Ehst BD,
    4. et al

    . Nephrogenic systemic fibrosis: incidence, associations, and effect of risk factor assessment: report of 33 cases. Radiology 2009; 250: 371–77

    CrossRefPubMedWeb of Science
33. 33.↵
    1. Di Chiro G,
    2. Knop RH,
    3. Girton MR,
    4. et al

    . MR cisternography and myelography with GD-GTPA in monkeys. Radiology 1985; 157: 373–77

    PubMed
34. 34.↵
    1. Di Chiro G,
    2. Girton ME,
    3. Frank JA,
    4. et al

    . Cerebrospinal fluid rhinorrhea: depiction with MR cisternography in dogs. Radiology 1986; 160: 221–22

    PubMed
35. 35.↵
    1. Jinkins JR,
    2. Williams RF,
    3. Xiong L

    . Evaluation of gadopentetate dimeglumine magnetic resonance cisternography in an animal model. Invest Radiol 1999; 34: 156–59

    CrossRefPubMed
36. 36.↵
    1. Ibarra R,
    2. Jinkins JR,
    3. Korvick D,
    4. et al

    . Evaluation of intrathecal gadolinium-enhanced MR cisternography in a rabbit model of traumatic nasoethmoidal CSF fistula. J Magn Reson Imaging 2000; 11: 20–24

    CrossRefPubMed
37. 37.↵
    1. Ray DE,
    2. Cavanagh JB,
    3. Nolan CC,
    4. et al

    . Neurotoxic effects of gadopentetate dimeglumine: behavioral disturbance and morphology after intracerebroventricular injection in rats. AJNR Am J Neuroradiol 1996; 17: 365–73

    Abstract
38. 38.↵
    1. Ray DE,
    2. Holton JL,
    3. Nolan CC,
    4. et al

    . Neurotoxic potential of gadodiamide after injection into the lateral cerebral ventricle of rats. AJNR Am J Neuroradiol 1998; 19: 1455–62

    Abstract
39. 39.↵
    1. Arlt S,
    2. Cepek L,
    3. Rustenbeck HH,
    4. et al

    . Gadolinium encephalopathy due to accidental intrathecal administration of gadopentetate dimeglumine. J Neurol 2007; 254: 810–12

    CrossRefPubMed
40. 40.↵
    1. Li L,
    2. Gao FQ,
    3. Zhang B,
    4. et al

    . Overdosage of intrathecal gadolinium and neurological response. Clin Radiol 2008; 63: 1063–68

    CrossRefPubMed
41. 41.↵
    1. Zeng QY,
    2. Xiong L,
    3. Jinkins JR,
    4. et al

    . Intrathecal gadolinium (gadopentetate dimeglumine)-enhanced MR myelography: a pilot study in human patients. AJR Am J Radiol 1999; 173: 1109–15

    PubMed
42. 42.↵
    1. Jinkins JR,
    2. Rudwan M,
    3. Krumina G,
    4. et al

    . Intrathecal gadolinium-enhanced MR cisternography in the evaluation of clinically suspected cerebrospinal fluid rhinorrhea in humans: early experience. Radiology 2002; 222: 555–59

    PubMedWeb of Science
43. 43.↵
    1. Tali ET,
    2. Ercan N,
    3. Krumina G,
    4. et al

    . Intrathecal gadolinium (gadopentetate dimeglumine)-enhanced magnetic resonance myelography and cisternography: results of a multicenter study. Invest Radiol 2002; 7: 152–59
44. 44.↵
    1. Reiche W,
    2. Komenda Y,
    3. Schick B,
    4. et al

    . MR cisternography after intrathecal Gd-DTPA application. Eur Radiol 2002; 12: 2943–49

    PubMed
45. 45.↵
    1. Aydin K,
    2. Guven K,
    3. Sencer S,
    4. et al

    . MRI cisternography with gadolinium-containing contrast medium: its role, advantages and limitations in the investigation of rhinorrhoea. Neuroradiology 2004; 46: 75–80

    CrossRefPubMed
46. 46.↵
    1. Muñoz A,
    2. Hinojosa J,
    3. Esparza J

    . Cisternography and ventriculography gadopentate dimeglumine-enhanced MR imaging in pediatric patients: preliminary report. AJNR Am J Neuroradiol 2007; 28: 889–94

    Abstract/FREE Full Text
47. 47.↵
    1. Aydin K,
    2. Terzibasioglu E,
    3. Sencer S,
    4. et al

    . Localization of cerebrospinal fluid leaks by gadolinium-enhanced magnetic resonance cisternography: a 5-year single-center experience. Neurosurgery 2008; 62: 584–89

    CrossRefPubMedWeb of Science
48. 48.↵
    1. Woodcock RJ,
    2. Marx WF,
    3. Johnson RM,
    4. et al

    . Needle diameter in outpatient myelography: rates of adverse effects and current practice trends. Neuroradiol 2000; 42: 371–74

    CrossRefPubMed